Difficult Choices!

LOTM is heavily werighted in

  1. Crypto/Blockchain and Precious Metals. Both Sectors are HOT.
    BUT
  2. Energy and BioTech are starting to emerge from Stage 1, base building chart patterns, and move into stage two chart patterns. Do we sell some or all of the first group to position into the groups that “appear” to be leaving their basebuilding patterns?

Our answer is that we are reluctant to leave Crypto/Blockchain and Precious Metals, but – we have identified a few undervalued companies (multi-baggers In My Opinion) in the Energy and Biotech sectors that we really like at their current prices. Therefore we are beginning to slowly add some names in a soft entry into energy and BioTech. We view biotech & genomic companies the same as we view price action of gold and silver. Gold movers first and silver later, but silver outperforms gold in the move. We think BioTech stocks will move first and Genomic stocks will move secondarly but move in a bigger percentage rally way than BioTech.

BioTech and Genomics is beyond my desire or ability to analize so we will primarly use actively managed ETFs in BioTech and Genomics proxies to the sector.

There are some names in both Energy and BioTech that pay high dividends. This is a foot in the water for LOTM as we then have a low risk entry in Energy and Biotech and can use the cash flows to spend in whatever direction we desire. Below are some high dividend names we own or like that have some Energy and BioTech positions:

Due your own reasearch about the companies and understand what you are buying. The above names are not a buy list because we do not know your personal situation. Review these companies with your personal investment adviser.

We have identified a number of names in the Energy and BioTech sectors that we believe are multibaggers, however they are thinly traded and still under accumulation by some accounts related to LOTM. Since we are a free service, we reserve the right to not mention the names until a future date.

Below is the monthly S&P BioTech ETF chart A graph with lines and numbers

AI-generated content may be incorrect.

Below is the monthly S&P Energy fund

LOTM likes small companies with experienced and proven managements, that trade at what is considered good value and where we see catalysts that will draw attention to the stock.

Therefore most of our ideas will not be in Funds or ETFs like XLE or XBI. They will lag the larger companies share prices but once a trend has been identified and labeled, these smaller companies’ share prices tend to outperform their bigger Brothers and Sisters in the sector. Therefore, we follow the perspective that wealth is created by Time “in the market” and not by “Timing the market.”

Much of our performance comes from mananageing positions for cost and taxes over the3 time we own the shares. Yes we Dollar-cost-average (DCA) rather than use stop losses as our risk management tool od choice.

LOTM Research & Consulting Service
* An account related to LOTM holds a position in this security.
Neither LOTM nor Tom Linzmeier is a Registered Investment Advisor.
Please refer to our web site for full disclosure at www.LivingOffTheMarket.com ZTA Capital Group, Inc.
To Unsubscribe please select “return” and type Unsubscribe in the subject line.

Loading

This entry was posted in Tom's Blog. Bookmark the permalink.